Tag: big pharma

Posted on November 13, 2016

BIG PHARMA AND HIGH COST BIOLOGICS: Raymond Rupert MD, MBA.

Sovaldi is a new biologic produced by Gilead Sciences to treat and cure hepatitis C. The cost for 2 months of treatment with Sovaldi in Egypt is $800. In Canada, Sovaldi costs $55,000. Gilead has a solid hold on the market for hepatitis C with 27 patents for Sovaldi. When analyzed, the patents are base […] Read More

Posted on December 9, 2015

HOW PHARMA CAN WIN IN THE DIGITAL WORLD: McKinsey- David Champagne (London), Amy Hung (New Jersey) & Olivier Leclerc (California)

The digital revolution continues to transform healthcare fundamentally, and many people believe that a tipping point is finally within reach. In 2014, digital health investments topped $6.5 billion, compared with $2.9 billion a year earlier.1 The critical question now for pharmaceutical companies is how to stay ahead of these changes. To answer it, we sought […] Read More